John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 135,854 shares at $6.17 ($928K) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Open-market sale of $928k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.17 | 14,722 | $91K | 9.8% |
| 2 | $6.17 | 14,722 | $91K | 9.8% |
| 3 | $6.62 | 22,127 | $146K | 15.8% |
| 4 | $6.62 | 22,127 | $146K | 15.8% |
| 5 | $7.29 | 31,078 | $227K | 24.4% |
| 6 | $7.29 | 31,078 |
| $227K |
| 24.4% |
| Total | $6.83 avg | 135,854 | $928K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |